MEDICC Rev. 2009 Jan;11(1):14-7. doi: 10.37757/MR2009V11.N1.4.
Immunologist by training, Dr Fernández Yero began his career in medical technology at the National Center for Scientific Research in Havana, working at the behest of several hospitals to develop the first Cuban alpha-fetoprotein test. It was the 1970s, a time when a single public health system was taking shape in Cuba and many of the main poverty-related social determinants of health had been tackled. "We were looking for technologies of the future," he says, "to see what we could do that could be applied throughout a national public health system." Sixteen generations of equipment later, Dr Fernández Yero heads the 21-year-old Immunoassay Center, a leader in the field of medical technology for population health. The road traveled has not been an easy one, lack of resources threatening delays and detours along the way. He shares his thoughts with MEDICC Review on his work, the meaning of appropriate technology and the challenges he foresees ahead.
作为一名免疫学家，Fernández Yero 博士在哈瓦那的国家科学研究中心开始了他的医学技术生涯，应几家医院的要求开发了第一个古巴甲胎蛋白测试。那是 20 世纪 70 年代，当时古巴正在形成单一的公共卫生系统，许多与贫困相关的主要健康决定因素已经得到解决。“我们在寻找未来的技术，”他说，“看看我们能做些什么，可以应用于整个国家的公共卫生系统。”经过 16 代设备的发展，Fernández Yero 博士领导着拥有 21 年历史的免疫分析中心，该中心是人口健康医学技术领域的领导者。一路走来并不容易，资源匮乏威胁着沿途的延迟和弯路。他在 MEDICC 评论上分享了他对工作、适当技术的意义以及他预见的挑战的看法。
